drugset
drugset / Trial / NCT00783939

Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Safety.

NCT00783939 ↗

Phase 3 Completed 31 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelSupportive care

Summary

The purpose of this study is to prove the safety in normal conditions of useof the product Dermacyd PH\_DETINBACK Tangerine Mix (Lactic Acid).

Timeline

Start
2008-09
Primary completion
2008-09
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactic Acid Other / unclassified — —

Indications

No indication recorded.